You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KROS Sale Disclosure
Newton Charles W. · SEC Form 4 · Filed Aug 20, 2026
Sale
Calculated transaction value
$5.68K
Newton Charles W. Director
KROS
Keros Therapeutics
KROS
Transaction date
Aug 18, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 2 days later
KROS daily price context
Close on/before transaction
$10.61
Aug 18, 2026
First close after public filing
$11.03
Aug 21, 2026
30-day return after filing
+4.08%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 551 shares @ $10.3
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001866219-26-000010
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$5.68K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Keros Therapeutics, Inc. KROS Current | Sale | Aug 18, 2026 | $5.68K |